Targeting the interleukin-15 system in rheumatoid arthritis

Authors

  • Thomas A. Waldmann

    Corresponding author
    1. NIH, Bethesda, Maryland
    • Metabolism Branch, CCR, NCI, 10 Center Drive, MSC 1374, Building 10, Room 4N115, NIH, Bethesda, MD 20892-1374
    Search for more papers by this author
    • Dr. Waldmann has a patent on interleukin-2 receptor (patent 5,833,983).


Ancillary